{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T16:02:57Z","timestamp":1758124977690,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":56,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071625125"},{"type":"electronic","value":"9781071625132"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-1-0716-2513-2_2","type":"book-chapter","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T14:04:50Z","timestamp":1658498690000},"page":"11-31","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Patient-Derived Breast Cancer Tissue Cultures for Anti-Endocrine Drug Assays"],"prefix":"10.1007","author":[{"given":"Giacomo","family":"Domenici","sequence":"first","affiliation":[]},{"given":"Gon\u00e7alo","family":"Trindade","sequence":"additional","affiliation":[]},{"given":"Marta F.","family":"Estrada","sequence":"additional","affiliation":[]},{"given":"Ana Lu\u00edsa","family":"Cartaxo","sequence":"additional","affiliation":[]},{"given":"Paula M.","family":"Alves","sequence":"additional","affiliation":[]},{"given":"Saudade","family":"Andr\u00e9","sequence":"additional","affiliation":[]},{"given":"Catarina","family":"Brito","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,7,23]]},"reference":[{"key":"2_CR1","first-page":"12","volume":"4","author":"EK Moriah","year":"2016","unstructured":"Moriah EK, Amanda LP, Andrew DW et al (2016) In vitro tumor models: advantages, disadvantages, variables, and selecting the right platform. Front Bioeng Biotechnol 4:12","journal-title":"Front Bioeng Biotechnol"},{"key":"2_CR2","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1126\/science.aao2774","volume":"359","author":"G Vlachogiannis","year":"2018","unstructured":"Vlachogiannis G, Hedayat S, Vatsiou A et al (2018) Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science 359:920\u2013926","journal-title":"Science"},{"issue":"2","key":"2_CR3","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s11060-018-03038-2","volume":"141","author":"M Tsoli","year":"2019","unstructured":"Tsoli M, Shen H, Mayoh C et al (2019) International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma. J Neuro-Oncol 141(2):253\u2013263","journal-title":"J Neuro-Oncol"},{"key":"2_CR4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/bcr2889","volume":"13","author":"DL Holliday","year":"2011","unstructured":"Holliday DL, Speirs V (2011) Choosing the right cell line for breast cancer research. Breast Cancer Res 13:215","journal-title":"Breast Cancer Res"},{"key":"2_CR5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.tibtech.2013.03.006","volume":"31","author":"A Mitra","year":"2013","unstructured":"Mitra A, Mishra L, Li S (2013) Technologies for deriving primary tumor cells for use in personalized cancer therapy. Trends Biotechnol 31:347\u2013354","journal-title":"Trends Biotechnol"},{"key":"2_CR6","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1158\/2159-8290.CD-16-1154","volume":"7","author":"C Pauli","year":"2017","unstructured":"Pauli C, Hopkins BD, Prandi D et al (2017) Personalized in vitro and in vivo cancer models to guide precision medicine. Cancer Discov 7:462\u2013477","journal-title":"Cancer Discov"},{"key":"2_CR7","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T Sorlie","year":"2001","unstructured":"Sorlie T, Perou CM, Tibshirani R et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci 98:10869\u201310874","journal-title":"Proc Natl Acad Sci"},{"key":"2_CR8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.ecl.2011.05.009","volume":"40","author":"D Germain","year":"2011","unstructured":"Germain D (2011) Estrogen carcinogenesis in breast cancer. Endocrinol Metab Clin N Am 40:473\u2013484","journal-title":"Endocrinol Metab Clin N Am"},{"key":"2_CR9","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s00204-012-0868-5","volume":"86","author":"KA Burns","year":"2012","unstructured":"Burns KA, Korach KS (2012) Estrogen receptors and human disease: an update. Arch Toxicol 86:1491\u20131504","journal-title":"Arch Toxicol"},{"key":"2_CR10","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1039\/C9MD00570F","volume":"11","author":"AI Shagufta","year":"2020","unstructured":"Shagufta AI, Mathew S et al (2020) Recent progress in selective estrogen receptor downregulators (SERDs) for the treatment of breast cancer. RSC Med Chem 11:438\u2013454","journal-title":"RSC Med Chem"},{"key":"2_CR11","doi-asserted-by":"crossref","unstructured":"Shagufta, Ahmad I (2018) Tamoxifen a pioneering drug: an update on the therapeutic potential of tamoxifen derivatives. Eur J Med Chem 143:515\u2013531","DOI":"10.1016\/j.ejmech.2017.11.056"},{"key":"2_CR12","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1038\/sj.bjc.6601629","volume":"90","author":"CK Osborne","year":"2004","unstructured":"Osborne CK, Wakeling A, Nicholson RI (2004) Fulvestrant: an estrogen receptor antagonist with a novel mechanism of action. Br J Cancer 90:S2\u2013S6","journal-title":"Br J Cancer"},{"key":"2_CR13","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1126\/science.270.5241.1491","volume":"270","author":"S Kato","year":"1995","unstructured":"Kato S, Endoh H, Masuhiro Y et al (1995) Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270:1491\u20131494","journal-title":"Science"},{"key":"2_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.12.012","volume":"186","author":"HK Patel","year":"2018","unstructured":"Patel HK, Bihani T (2018) Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment. Pharmacol Ther 186:1\u201324","journal-title":"Pharmacol Ther"},{"key":"2_CR15","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/S0960-9776(19)31118-X","volume":"48","author":"JT Lei","year":"2019","unstructured":"Lei JT, Anurag M, Haricharan S et al (2019) Endocrine therapy resistance: new insights. Breast 48:S26\u2013S30","journal-title":"Breast"},{"key":"2_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nbt.2786","volume":"32","author":"M Hay","year":"2014","unstructured":"Hay M, Thomas DW, Craighead JL et al (2014) Clinical development success rates for investigational drugs. Nat Biotechnol 32:40\u201351","journal-title":"Nat Biotechnol"},{"key":"2_CR17","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1242\/jcs.00523","volume":"116","author":"V Novaro","year":"2003","unstructured":"Novaro V, Roskelley CD, Bissell MJ (2003) Collagen-IV and laminin-1 regulate estrogen receptor \u03b1 expression and function in mouse mammary epithelial cells. J Cell Sci 116:2975\u20132986","journal-title":"J Cell Sci"},{"key":"2_CR18","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ccell.2016.02.002","volume":"29","author":"G Sflomos","year":"2016","unstructured":"Sflomos G, Dormoy V, Metsalu T et al (2016) A preclinical model for ER\u03b1-positive breast cancer points to the epithelial microenvironment as determinant of luminal phenotype and hormone response. Cancer Cell 29:407\u2013422","journal-title":"Cancer Cell"},{"key":"2_CR19","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature12626","volume":"501","author":"MR Junttila","year":"2013","unstructured":"Junttila MR, de Sauvage FJ (2013) Influence of tumor micro-environment heterogeneity on therapeutic response. Nature 501:346\u2013354","journal-title":"Nature"},{"key":"2_CR20","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.3390\/ijms22041972","volume":"22","author":"N Lopes","year":"2021","unstructured":"Lopes N, Correia VG, Palma AS et al (2021) Cracking the breast cancer glyco-code through glycan-lectin interactions: targeting immunosuppressive macrophages. Int J Mol Sci 22:1972","journal-title":"Int J Mol Sci"},{"key":"2_CR21","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3389\/fendo.2019.00547","volume":"10","author":"MI Diaz Bessone","year":"2019","unstructured":"Diaz Bessone MI, Gattas MJ, Laporte T et al (2019) The tumor microenvironment as a regulator of endocrine resistance in breast cancer. Front Endocrinol 10:547","journal-title":"Front Endocrinol"},{"key":"2_CR22","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3390\/ijms19020615","volume":"19","author":"G Colella","year":"2018","unstructured":"Colella G, Fazioli F, Gallo M et al (2018) Sarcoma spheroids and organoids-promising tools in the era of personalized medicine. Int J Mol Sci 19:615","journal-title":"Int J Mol Sci"},{"issue":"14","key":"2_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201806590","volume":"31","author":"MA Heinrich","year":"2019","unstructured":"Heinrich MA, Bansal R, Lammers T et al (2019) 3D-bioprinted mini-brain: a glioblastoma model to study cellular interactions and therapeutics. Adv Mater 31(14):e1806590","journal-title":"Adv Mater"},{"key":"2_CR24","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.biomaterials.2015.11.030","volume":"78","author":"MF Estrada","year":"2016","unstructured":"Estrada MF, Rebelo SP, Davies EJ et al (2016) Modelling the tumor microenvironment in long-term microencapsulated 3D co-cultures recapitulates phenotypic features of disease progression. Biomaterials 78:50\u201361","journal-title":"Biomaterials"},{"key":"2_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.biomaterials.2018.02.030","volume":"163","author":"SP Rebelo","year":"2018","unstructured":"Rebelo SP, Pinto C, Martins TR et al (2018) 3D-3-culture: a tool to unveil macrophage plasticity in the tumor microenvironment. Biomaterials 163:185\u2013197","journal-title":"Biomaterials"},{"key":"2_CR26","doi-asserted-by":"publisher","first-page":"114","DOI":"10.21037\/atm.2019.12.88","volume":"8","author":"HL Kenerson","year":"2020","unstructured":"Kenerson HL, Sullivan KM, Seo YD et al (2020) Tumor slice culture as a biologic surrogate of human cancer. Ann Transl Med 8:114\u2013114","journal-title":"Ann Transl Med"},{"key":"2_CR27","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/978-1-4939-8885-3_20","volume":"1884","author":"X Jiang","year":"2019","unstructured":"Jiang X, Seo YD, Sullivan KM et al (2019) Establishment of slice cultures as a tool to study the cancer immune microenvironment. Methods Mol Biol 1884:283\u2013295","journal-title":"Methods Mol Biol"},{"key":"2_CR28","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1471-2407-6-86","volume":"6","author":"H van der Kuip","year":"2006","unstructured":"van der Kuip H, M\u00fcrdter TE, Sonnenberg M et al (2006) Short term culture of breast cancer tissues to study the activity of the anticancer drug taxol in an intact tumor environment. BMC Cancer 6:86","journal-title":"BMC Cancer"},{"key":"2_CR29","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1136\/jclinpath-2012-201147","volume":"66","author":"DL Holliday","year":"2013","unstructured":"Holliday DL, Moss MA, Pollock S et al (2013) The practicalities of using tissue slices as preclinical organotypic breast cancer models. J Clin Pathol 66:253\u2013255","journal-title":"J Clin Pathol"},{"key":"2_CR30","volume":"6","author":"MG Muraro","year":"2017","unstructured":"Muraro MG, Muenst S, Mele V et al (2017) Ex-vivo assessment of drug response on breast cancer primary tissue with preserved microenvironments. Onco Targets Ther 6:e1331798","journal-title":"Onco Targets Ther"},{"key":"2_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2014.06.005","volume":"79\u201380","author":"G Benton","year":"2014","unstructured":"Benton G, Arnaoutova I, George J et al (2014) Matrigel: from discovery and ECM mimicry to assays and models for cancer research. Adv Drug Deliv Rev 79\u201380:3\u201318","journal-title":"Adv Drug Deliv Rev"},{"key":"2_CR32","doi-asserted-by":"publisher","first-page":"1903975","DOI":"10.1002\/adma.201903975","volume":"32","author":"VM Gaspar","year":"2020","unstructured":"Gaspar VM, Lavrador P, Borges J et al (2020) Advanced bottom-up engineering of living architectures. Adv Mater 32:1903975","journal-title":"Adv Mater"},{"key":"2_CR33","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.3390\/cancers12102754","volume":"12","author":"T Nii","year":"2020","unstructured":"Nii T, Makino K, Tabata Y (2020) Three-dimensional culture system of cancer cells combined with biomaterials for drug screening. Cancers 12:2754","journal-title":"Cancers"},{"key":"2_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119744","volume":"232","author":"V Brancato","year":"2020","unstructured":"Brancato V, Oliveira JM, Correlo VM et al (2020) Could 3D models of cancer enhance drug screening? Biomaterials 232:119744","journal-title":"Biomaterials"},{"key":"2_CR35","doi-asserted-by":"publisher","first-page":"118627","DOI":"10.1016\/j.ijpharm.2019.118627","volume":"569","author":"D Dhamecha","year":"2019","unstructured":"Dhamecha D, Movsas R, Sano U et al (2019) Applications of alginate microspheres in therapeutics delivery and cell culture: past, present and future. Int J Pharm 569:118627","journal-title":"Int J Pharm"},{"key":"2_CR36","doi-asserted-by":"publisher","first-page":"4917","DOI":"10.2174\/1381612821666150820105639","volume":"21","author":"S Giovagnoli","year":"2015","unstructured":"Giovagnoli S, Luca G, Blasi P et al (2015) Alginates in pharmaceutics and biomedicine: is the future so bright? Curr Pharm Des 21:4917\u20134935","journal-title":"Curr Pharm Des"},{"key":"2_CR37","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1080\/09205063.2019.1622185","volume":"30","author":"X Mi","year":"2019","unstructured":"Mi X, Wang X, Xu C et al (2019) Alginate microspheres prepared by ionic cross-linking of pickering alginate emulsions. J Biomater Sci Polym Ed 30:1083\u20131096","journal-title":"J Biomater Sci Polym Ed"},{"key":"2_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-34523-3","volume":"8","author":"N Bay\u00f3-Puxan","year":"2018","unstructured":"Bay\u00f3-Puxan N, Terrasso AP, Creyssels S et al (2018) Lysosomal and network alterations in human mucopolysaccharidosis type VII iPSC-derived neurons. Sci Rep 8:16644","journal-title":"Sci Rep"},{"key":"2_CR39","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1089\/ten.tec.2009.0660","volume":"16","author":"R Malpique","year":"2010","unstructured":"Malpique R, Os\u00f3rio LM, Ferreira DS et al (2010) Alginate encapsulation as a novel strategy for the cryopreservation of neurospheres. Tissue Eng Part C Methods 16:965\u2013977","journal-title":"Tissue Eng Part C Methods"},{"key":"2_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023212","volume":"6","author":"M Serra","year":"2011","unstructured":"Serra M, Correia C, Malpique R et al (2011) Microencapsulation technology: a powerful tool for integrating expansion and cryopreservation of human embryonic stem cells. PLoS One 6:e23212","journal-title":"PLoS One"},{"key":"2_CR41","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3390\/cancers13040879","volume":"13","author":"G Domenici","year":"2021","unstructured":"Domenici G, Eduardo R, Castillo-Ecija H et al (2021) PDX-derived Ewing\u2019s sarcoma cells retain high viability and disease phenotype in alginate encapsulated spheroid cultures. Cancers 13:879","journal-title":"Cancers"},{"key":"2_CR42","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jbiotec.2016.01.031","volume":"221","author":"VE Santo","year":"2016","unstructured":"Santo VE, Estrada MF, Rebelo SP et al (2016) Adaptable stirred-tank culture strategies for large scale production of multicellular spheroid-based tumor cell models. J Biotechnol 221:118\u2013129","journal-title":"J Biotechnol"},{"key":"2_CR43","doi-asserted-by":"crossref","unstructured":"Rebelo SP, Pinto C, Lopes N et al (2020) 3D-3-culture: tumor models to study heterotypic interactions in the tumor microenvironment. Methods Pharmacol Toxicol:117\u2013130","DOI":"10.1007\/978-1-0716-0171-6_8"},{"key":"2_CR44","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13046-020-01653-4","volume":"39","author":"AL Cartaxo","year":"2020","unstructured":"Cartaxo AL, Estrada MF, Domenici G et al (2020) A novel culture method that sustains ER\u03b1 signaling in human breast cancer tissue microstructures. J Exp Clin Cancer Res 39:161","journal-title":"J Exp Clin Cancer Res"},{"key":"2_CR45","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1093\/jnci\/djx270","volume":"110","author":"LS Lindstr\u00f6m","year":"2018","unstructured":"Lindstr\u00f6m LS, Yau C, Czene K et al (2018) Intratumor heterogeneity of the estrogen receptor and the long-term risk of fatal breast cancer. J Natl Cancer Inst 110:726\u2013733","journal-title":"J Natl Cancer Inst"},{"key":"2_CR46","doi-asserted-by":"publisher","first-page":"15081","DOI":"10.1038\/ncomms15081","volume":"8","author":"W Chung","year":"2017","unstructured":"Chung W, Eum HH, Lee H-O et al (2017) Single-cell RNA-seq enables comprehensive tumor and immune cell profiling in primary breast cancer. Nat Commun 8:15081","journal-title":"Nat Commun"},{"key":"2_CR47","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1002\/1878-0261.12354","volume":"12","author":"MM Centenera","year":"2018","unstructured":"Centenera MM, Hickey TE, Jindal S et al (2018) A patient-derived explant ( PDE) model of hormone-dependent cancer. Mol Oncol 12:1608\u20131622","journal-title":"Mol Oncol"},{"key":"2_CR48","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative CT method. Nat Protoc 3:1101\u20131108","journal-title":"Nat Protoc"},{"key":"2_CR49","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1038\/s41388-018-0656-7","volume":"38","author":"G Domenici","year":"2019","unstructured":"Domenici G, Aurrekoetxea-Rodr\u00edguez I, Sim\u00f5es BM et al (2019) A Sox2-Sox9 signaling axis maintains human breast luminal progenitor and breast cancer stem cells. Oncogene 38:3151\u20133169","journal-title":"Oncogene"},{"key":"2_CR50","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Method 25:402\u2013408","journal-title":"Method"},{"key":"2_CR51","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0960-0760(94)90072-8","volume":"48","author":"M Borr\u00e1s","year":"1994","unstructured":"Borr\u00e1s M, Hardy L, Lempereur F et al (1994) Estradiol-induced Down-regulation of estrogen receptor. Effect of various modulators of protein synthesis and expression. J Steroid Biochem Mol Biol 48:325\u2013336","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2_CR52","doi-asserted-by":"publisher","first-page":"5191","DOI":"10.1021\/acsbiomaterials.0c00806","volume":"6","author":"P Chansoria","year":"2020","unstructured":"Chansoria P, Narayanan LK, Wood M et al (2020) Effects of autoclaving, EtOH, and UV sterilization on the chemical, mechanical, printability, and biocompatibility characteristics of alginate. ACS Biomater Sci Eng 6:5191\u20135201","journal-title":"ACS Biomater Sci Eng"},{"key":"2_CR53","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1021\/bp00001a008","volume":"6","author":"WJ Leo","year":"1990","unstructured":"Leo WJ, Mcloughlin AJ, Malone DM (1990) Effects of sterilization treatments on some properties of alginate solutions and gels. Biotechnol Prog 6:51\u201353","journal-title":"Biotechnol Prog"},{"key":"2_CR54","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/1471-2407-14-283","volume":"14","author":"M Moerkens","year":"2014","unstructured":"Moerkens M, Zhang Y, Wester L et al (2014) Epidermal growth factor receptor signaling in human breast cancer cells operates parallel to estrogen receptor \u03b1 signaling and results in tamoxifen insensitive proliferation. BMC Cancer 14:283","journal-title":"BMC Cancer"},{"key":"2_CR55","doi-asserted-by":"publisher","first-page":"597","DOI":"10.2174\/156800908786241104","volume":"8","author":"M Lanzino","year":"2008","unstructured":"Lanzino M, Morelli C, Garofalo C et al (2008) Interaction between estrogen receptor alpha and insulin\/IGF signaling in breast cancer. Curr Cancer Drug Targets 8:597\u2013610","journal-title":"Curr Cancer Drug Targets"},{"key":"2_CR56","doi-asserted-by":"publisher","first-page":"24020","DOI":"10.1074\/jbc.M113.473819","volume":"288","author":"S Karmakar","year":"2013","unstructured":"Karmakar S, Jin Y, Nagaich AK (2013) Interaction of glucocorticoid receptor (GR) with estrogen receptor (ER) \u03b1 and activator protein 1 (AP1) in dexamethasone-mediated interference of ER\u03b1 activity. J Biol Chem 288:24020\u201324034","journal-title":"J Biol Chem"}],"container-title":["Methods in Molecular Biology","Cancer Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-2513-2_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T14:05:09Z","timestamp":1658498709000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-2513-2_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9781071625125","9781071625132"],"references-count":56,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-2513-2_2","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"23 July 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}